While these liver-specific ABHD5-deficient mice similarly developed hepatic steatosis associated with decreased hepatic TAG hydrolase activity and reduced FA oxidation rates, they exhibited plasma TAG concentrations and VLDL production rates comparable to their wild-type littermates. Here, DDHD2 is linked to fatty liver disease.